AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (March 19, 2008). doi:10.1152/ajpregu.00840.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/5/R1737    most recent
00840.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorneloe, K. S
Right arrow Articles by Nelson, M. T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorneloe, K. S
Right arrow Articles by Nelson, M. T
Submitted on November 30, 2006
Accepted on March 10, 2008

Small conductance, Ca2+- activated K+ channel 2 (SK2) is the key functional component of SK channels in mouse urinary bladder

Kevin S Thorneloe1*, Anna M Knorn2, Paul E Doetsch2, Erin SR Lashinger3, Aixue X Liu3, Chris T. Bond4, John P. Adelman4, and Mark T Nelson5

1 Pharmacology, University of Vermont, Burlington, Vermont, United States; Urogenital Biology, Cardiovascular and Urogenital Center of Excellence in Drug Discovery, GlaxoSmithKline Pharmaceuticals, king of prussia, Pennsylvania, United States
2 Pharmacology, University of Vermont, Burlington, Vermont, United States
3 Urogenital Biology, Cardiovascular and Urogenital Center of Excellence in Drug Discovery, GlaxoSmithKline Pharmaceuticals, king of prussia, Pennsylvania, United States
4 4435A Vollum Institute, Oregon Health Sci Univ, Portland, Oregon, United States
5 Pharmacology, University of Vermont, Burlington, United States

* To whom correspondence should be addressed. E-mail: kevin.s.thorneloe{at}gsk.com.

Small-conductance Ca2+- activated K+ (SK) channels play an important role in regulating the frequency, and in shaping urinary bladder smooth muscle (UBSM) action potentials, thereby modulating contractility. Here we investigated a role for the SK2 member of the SK family (SK1-3) utilizing: 1) mice expressing {beta}-galactosidase ({beta}-gal) under the direction of the SK2 promoter (SK2 {beta}-gal mice) to localize SK2 expression and, 2) mice lacking SK2 gene expression (SK2-/- mice) to assess SK2 function. In SK2 {beta}-gal mice UBSM staining was observed, but staining was undetected in the urothelium. Consistent with this urothelial SK2 mRNA was determined to be 4% of that in UBSM. Spontaneous phasic contractions in wild-type (SK2+/+) UBSM strips were potentiated (259% of control) by the selective SK channel blocker apamin (EC50 = 0.16 nM), whereas, phasic contractions of SK2-/- strips were unaffected. Nerve-mediated contractions of SK2+/+ UBSM strips were also increased by apamin, an effect absent in SK2-/- strips. Apamin increased the sensitivity of SK2+/+ UBSM strips to electrical field stimulation, as pretreatment with apamin decreased the frequency required to reach a 50% maximal contraction (vehicle, 21 ± 4 Hz, n=6; apamin, 12 ± 2 Hz, n=7; p<0.05). In contrast, the sensitivity of SK2-/- UBSM strips was unaffected by apamin. Here we provide novel insight into the molecular basis of SK channels in the urinary bladder, demonstrating that the SK2 gene is expressed in the bladder and that it is essential for the ability of SK channels to regulate UBSM contractility.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.